Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 55 of 57
Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
NCT00482378
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
NCT00275717
Patient Preference With Visicol Tablet Preparation for Colonoscopy
NCT00318305
Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram
NCT00613470
Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.
NCT00217009
A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
NCT00217152
Use of Tamoxifen in Systemic Mastocytosis
NCT01334996
A Brief Dental Office Intervention With Tobacco Quitline
NCT00273156
Development of a Hospital Service That Uses Critical Pathway (Protocolized) Care Plans to Provide High-Quality, High-Reliability, Evidence-Based Medical Care
NCT00275587
Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
NCT00330525
Structured Multidisciplinary Intervention or Standard Medical Care in Improving Quality of Life in Patients Receiving Active Cancer Treatment
NCT01360814
Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers
NCT01094821
A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation
NCT00166556
Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome
NCT00955994
Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance
NCT00588822
The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant
NCT00275639
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
NCT00655655
Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients
NCT00169936
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia
NCT00436904
Aortic Distensibility
NCT00587977
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT00170170
Precision of the Magnetocardiographer for Data Aquision and Analysis.
NCT00170014
Ramanspectroscopy in Barrett's Esophagus
NCT00588575
A Multivitamin Comparison Study in Kidney Transplant Recipients.
NCT00217100
Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma
NCT00438880
Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies
NCT00295243
A Prospective Trial of Elective Extubation in Brain Injured Patients.
NCT00729261
Rituximab in Membranous Nephropathy
NCT00425217
Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.
NCT00169975
Long-term Effects of Laser Refractive Surgery
NCT00350246
Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients
NCT00282698
Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C
NCT00275548
Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus
NCT00308373
A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.
NCT00166400
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
NCT00170157
Computer Assisted Total Knee Replacement
NCT00279838
Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy
NCT00607880
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.
NCT00275652
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
NCT00587210
Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms
NCT02158039
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
NCT00408590
Characterization of the Essure System Tubal Sterilization Using Ultrasound and X-Ray
NCT00588497
Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent
NCT00166361
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197
Diagnostic Accuracy of Capsule Endoscopy in Small Bowel Crohn's Disease
NCT00588653
Acupuncture and Hot Flashes
NCT00217074
Primary Hyperoxaluria Mutation Genotyping
NCT00589225
BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED
NCT00587938
Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases
NCT00608855
Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies
NCT00275678
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.